sb 239063 has been researched along with Injury, Myocardial Reperfusion in 2 studies
SB 239063: structure in first source
SB-239063 : A member of the class of imidazoles carrying 4-hydroxycyclohexyl, 4-fluorophenyl and 2-methoxypyrimidin-4-yl substituents at positions 1, 4 and 5 respectively.
Excerpt | Relevance | Reference |
---|---|---|
"However, the effect of p38 MAPK on myocardial reperfusion injury, a pathologic condition involving a typical inflammatory response, has not been fully examined." | 1.31 | p38 MAPK inhibition reduces myocardial reperfusion injury via inhibition of endothelial adhesion molecule expression and blockade of PMN accumulation. ( Barone, FC; Christopher, TA; Gao, F; Lopez, BL; Ma, XL; Ohlstein, EH; Shi, DW; Yue, TL, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chai, W | 1 |
Wu, Y | 1 |
Li, G | 1 |
Cao, W | 1 |
Yang, Z | 1 |
Liu, Z | 1 |
Gao, F | 1 |
Yue, TL | 1 |
Shi, DW | 1 |
Christopher, TA | 1 |
Lopez, BL | 1 |
Ohlstein, EH | 1 |
Barone, FC | 1 |
Ma, XL | 1 |
2 other studies available for sb 239063 and Injury, Myocardial Reperfusion
Article | Year |
---|---|
Activation of p38 mitogen-activated protein kinase abolishes insulin-mediated myocardial protection against ischemia-reperfusion injury.
Topics: Animals; Anisomycin; Cardiotonic Agents; Drug Interactions; Enzyme Activation; Enzyme Inhibitors; Hy | 2008 |
p38 MAPK inhibition reduces myocardial reperfusion injury via inhibition of endothelial adhesion molecule expression and blockade of PMN accumulation.
Topics: Analysis of Variance; Animals; Endothelium, Vascular; Imidazoles; Intercellular Adhesion Molecule-1; | 2002 |